AAAAAA
Results: 1-25/282
Authors:
HOMBACH A
TILLMANN T
JENSEN M
HEUSER C
SIRCAR R
DIEHL V
KRUIS W
POHL C
Citation: A. Hombach et al., SPECIFIC ACTIVATION OF RESTING T-CELLS AGAINST CA19-9-CELLS BY AN ANTI-CD3( TUMOR)CA19-9 BISPECIFIC ANTIBODY IN COMBINATION WITH A COSTIMULATORY ANTI-CD28 ANTIBODY/, Journal of immunotherapy with emphasis on tumor immunology, 20(5), 1997, pp. 325-333
Authors:
TSENG SH
HWANG LH
LIN SM
Citation: Sh. Tseng et al., INDUCTION OF ANTITUMOR IMMUNITY BY INTRACEREBRALLY IMPLANTED RAT C6 GLIOMA-CELLS GENETICALLY-ENGINEERED TO SECRETE CYTOKINES, Journal of immunotherapy with emphasis on tumor immunology, 20(5), 1997, pp. 334-342
Authors:
VANELSAS A
AARNOUDSE C
VANDERMINNE CE
VANDERSPEK CW
BROUWENSTIJN N
OSANTO S
SCHRIER PI
Citation: A. Vanelsas et al., TRANSFECTION OF IL-2 AUGMENTS CTL RESPONSE TO HUMAN-MELANOMA CELLS IN-VITRO - IMMUNOLOGICAL CHARACTERIZATION OF A MELANOMA VACCINE, Journal of immunotherapy with emphasis on tumor immunology, 20(5), 1997, pp. 343-353
Authors:
CHEN YM
YANG WK
WHANGPENG J
TSAI WY
HUNG YM
YANG DM
LIN WC
PERNG RP
TING CC
Citation: Ym. Chen et al., RESTORATION OF THE IMMUNOCOMPETENCE BY IL-2 ACTIVATION AND TCR-CD3 ENGAGEMENT OF THE IN-VIVO ANERGIZED TUMOR-SPECIFIC CTL FROM LUNG-CANCER PATIENTS, Journal of immunotherapy with emphasis on tumor immunology, 20(5), 1997, pp. 354-364
Authors:
HENNEMANN B
REHM A
KOTTKE A
MEIDENBAUER N
ANDREESEN R
Citation: B. Hennemann et al., ADOPTIVE IMMUNOTHERAPY WITH TUMOR-CYTOTOXIC MACROPHAGES DERIVED FROM RECOMBINANT HUMAN GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR (RHUGM-CSF) MOBILIZED PERIPHERAL-BLOOD MONOCYTES, Journal of immunotherapy with emphasis on tumor immunology, 20(5), 1997, pp. 365-371
Authors:
DORAN T
STUHLMILLER H
KIM JA
MARTIN EW
TRIOZZI PL
Citation: T. Doran et al., ONCOGENE AND CYTOKINE EXPRESSION OF HUMAN COLORECTAL TUMORS RESPONDING TO IMMUNOTHERAPY, Journal of immunotherapy with emphasis on tumor immunology, 20(5), 1997, pp. 372-376
Authors:
SCHILTZ PM
BEUTEL LD
NAYAK SK
DILLMAN RO
Citation: Pm. Schiltz et al., CHARACTERIZATION OF TUMOR-INFILTRATING LYMPHOCYTES DERIVED FROM HUMANTUMORS FOR USE AS ADOPTIVE IMMUNOTHERAPY OF CANCER, Journal of immunotherapy with emphasis on tumor immunology, 20(5), 1997, pp. 377-386
Authors:
LOGAN TF
GOODING WE
WHITESIDE TL
ERNSTOFF MS
KAPLAN SS
MIKETIC L
VLOCK DR
TOMPKINS C
WOOD DL
NADLER PI
KIRKWOOD JM
Citation: Tf. Logan et al., BIOLOGIC RESPONSE MODULATION BY TUMOR-NECROSIS-FACTOR-ALPHA (TNF-ALPHA) IN A PHASE IB TRIAL IN CANCER-PATIENTS, Journal of immunotherapy with emphasis on tumor immunology, 20(5), 1997, pp. 387-398
Citation: ABSTRACTS - 12TH ANNUAL-MEETING OF THE SOCIETY-FOR-BIOLOGICAL-THERAPY- OCTOBER 22-25, 1997 - PASADENA, CALIFORNIA, Journal of immunotherapy with emphasis on tumor immunology, 20(5), 1997, pp. 399-421
Authors:
SHILYANSKY J
YANG JC
CUSTER MC
SPIESS P
MIXON A
COLE DJ
MULE JJ
ROSENBERG SA
NISHIMURA MI
Citation: J. Shilyansky et al., IDENTIFICATION OF A T-CELL RECEPTOR FROM A THERAPEUTIC MURINE T-CELL CLONE, Journal of immunotherapy with emphasis on tumor immunology, 20(4), 1997, pp. 247-255
Authors:
KOMATA T
TANAKA R
YAMAMOTO K
ODA T
ONO K
YOSHIDA S
TAKAHASHI M
Citation: T. Komata et al., B7-1(CD80)-TRANSFECTED HUMAN GLIOMA-CELLS AND INTERLEUKIN-12 DIRECTLYSTIMULATE ALLOGENEIC CD8(-CELLS() T), Journal of immunotherapy with emphasis on tumor immunology, 20(4), 1997, pp. 256-264
Authors:
CHEN PW
MURRAY TG
SALGALLER ML
KSANDER BR
Citation: Pw. Chen et al., EXPRESSION OF MAGE GENES IN OCULAR MELANOMA CELL-LINES, Journal of immunotherapy with emphasis on tumor immunology, 20(4), 1997, pp. 265-275
Authors:
KIM CJ
PREVETTE T
CORMIER J
OVERWIJK W
RODEN M
RESTIFO NP
ROSENBERG SA
MARINCOLA FM
Citation: Cj. Kim et al., DENDRITIC CELLS INFECTED WITH POXVIRUSES ENCODING - MART-1 MELAN-A SENSITIZE T-LYMPHOCYTES IN-VITRO, Journal of immunotherapy with emphasis on tumor immunology, 20(4), 1997, pp. 276-286
Authors:
EPZSTEYN S
VITETTA ES
YEFENOF E
Citation: S. Epzsteyn et al., PROPHYLACTIC INTERVENTION IN RADLV-INDUCED LYMPHOMAGENESIS WITH AN ANTI-IL-4 MONOCLONAL-ANTIBODY, Journal of immunotherapy with emphasis on tumor immunology, 20(4), 1997, pp. 287-291
Authors:
CORMIER JN
HURST R
VASSELLI J
LEE D
KIM CJ
MCKEE M
VENZON D
WHITE D
MARINCOLA FM
ROSENBERG SA
Citation: Jn. Cormier et al., A PROSPECTIVE RANDOMIZED EVALUATION OF THE PROPHYLACTIC USE OF LOW-DOSE DOPAMINE IN CANCER-PATIENTS RECEIVING INTERLEUKIN-2, Journal of immunotherapy with emphasis on tumor immunology, 20(4), 1997, pp. 292-300
Authors:
BUKOWSKI RM
OLENCKI T
WANG Q
PEEREBOOM D
BUDD GT
ELSON P
SANDSTROM K
TUASON L
RAYMAN P
TUBBS R
MCLAIN D
KLEIN E
NOVICK A
FINKE J
Citation: Rm. Bukowski et al., PHASE-II TRIAL OF INTERLEUKIN-2 AND INTERFERON-ALPHA IN PATIENTS WITHRENAL-CELL CARCINOMA - CLINICAL-RESULTS AND IMMUNOLOGICAL CORRELATES OF RESPONSE, Journal of immunotherapy with emphasis on tumor immunology, 20(4), 1997, pp. 301-311
Authors:
KRUIT WHJ
GOEY SH
LAMERS CHJ
GRATAMA JW
VISSER B
SCHMITZ PIM
EGGERMONT AMM
BOLHUIS RLH
STOTER G
Citation: Whj. Kruit et al., HIGH-DOSE REGIMEN OF INTERLEUKIN-2 AND INTERFERON-ALPHA IN COMBINATION WITH LYMPHOKINE-ACTIVATED KILLER-CELLS IN PATIENTS WITH METASTATIC RENAL-CELL-CANCER, Journal of immunotherapy with emphasis on tumor immunology, 20(4), 1997, pp. 312-320
Authors:
WOJTOWICZPRAGA S
Citation: S. Wojtowiczpraga, REVERSAL OF TUMOR-INDUCED IMMUNOSUPPRESSION - A NEW APPROACH TO CANCER-THERAPY, Journal of immunotherapy with emphasis on tumor immunology, 20(3), 1997, pp. 165-177
Authors:
MARINCOLA FM
Citation: Fm. Marincola, COMMENTARY - THE MULTIPLE WAYS TO TUMOR TOLERANCE, Journal of immunotherapy with emphasis on tumor immunology, 20(3), 1997, pp. 178-179
Authors:
KEDAR E
PALGI O
GOLOD G
BABAI I
BARENHOLZ Y
Citation: E. Kedar et al., DELIVERY OF CYTOKINES BY LIPOSOMES .3. LIPOSOME-ENCAPSULATED GM-CSF AND TNF-ALPHA SHOW IMPROVED PHARMACOKINETICS AND BIOLOGICAL-ACTIVITY AND REDUCED TOXICITY IN MICE, Journal of immunotherapy with emphasis on tumor immunology, 20(3), 1997, pp. 180-193
Authors:
THAKUR ML
LI J
DONEGAN M
PALLELA VR
KOLAN H
DUGGARAJU R
MAISH D
SRIVASTAVA S
Citation: Ml. Thakur et al., IMPROVED ANTIBODY TARGETING WITH INTERFERON-ALPHA-2B CONJUGATE, Journal of immunotherapy with emphasis on tumor immunology, 20(3), 1997, pp. 194-201
Authors:
SLEIJFER S
VANGINKEL RJ
VANDERMARK TW
HOEKSTRA HJ
ZWAVELING JH
KOOPS HS
MULDER NH
Citation: S. Sleijfer et al., EFFECTS OF HYPERTHERMIC ISOLATED LIMB PERFUSION WITH TUMOR-NECROSIS-FACTOR-ALPHA AND MELPHALAN ON PULMONARY-FUNCTION ASSESSMENTS, Journal of immunotherapy with emphasis on tumor immunology, 20(3), 1997, pp. 202-207
Authors:
DAVISDANESHFAR A
BONI R
VONWUSSOW P
JOLLER H
BURG G
DUMMER R
Citation: A. Davisdaneshfar et al., ADJUVANT IMMUNOTHERAPY IN MALIGNANT-MELANOMA - IMPACT OF ANTIBODY-FORMATION AGAINST INTERFERON-ALPHA ON IMMUNOPARAMETERS IN-VIVO, Journal of immunotherapy with emphasis on tumor immunology, 20(3), 1997, pp. 208-213
Authors:
MIELE L
Citation: L. Miele, POINTS TO CONSIDER IN THE MANUFACTURE AND TESTING OF MONOCLONAL-ANTIBODY PRODUCTS FOR HUMAN USE (1997), Journal of immunotherapy with emphasis on tumor immunology, 20(3), 1997, pp. 214-243
Authors:
SMITH M
Citation: M. Smith, CONSIDERATIONS ON A POSSIBLE VIRAL ETIOLOGY FOR B-PRECURSOR ACUTE LYMPHOBLASTIC-LEUKEMIA OF CHILDHOOD, Journal of immunotherapy with emphasis on tumor immunology, 20(2), 1997, pp. 89-100